Sanguine BioSciences Receives Seed Financing Round

  • Feed Type
  • Date
    2/22/2013
  • Company Name
    Sanguine BioSciences
  • Mailing Address
    28903 Avenue Paine Valencia, CA 91355
  • Company Description
    Our mission is to facilitate and accelerate biomarker and personalized drug discovery by acknowledging the powerful role of the patient in research. We strive to develop meaningful relationships with patients that lead to empowerment and education. The Patient Portal will provide you information on how YOU can help accelerate research and treatments for your disease.
  • Website
    http://www.sanguinebio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    Undisclosed
  • Transaction Round
    Seed
  • Proceeds Purposes
    Sanguine plans to use the funds to scale its infrastructure to collect, process, document and store up to 1,000 blood samples a month on the West Coast.
  • M&A Terms
  • Venture Investor
    Invent Ventures
  • Venture Investor
    Heliant Ventures

By posting a comment, you agree to our terms and conditions.